Skip to main content
. 2016 Nov 26;25(Suppl 2):5. doi: 10.11604/pamj.supp.2016.25.2.9203

Table 3.

Multivariate logistic regression analysis of determinant factors for MDR-TB

Factors Options MDR TB N=103 Non MDR TB N=103 COR (95%CI) Adjusted Odds Ratio (AOR) (95% CI)
Sex Male 49(47.6%) 64(62.1%) 1 1
Female 54(52.4%) 39(37.9%) 1.808(1.04,3.15) 3.05(0.94,9.84)
Had history of pervious TB Yes 96(93.2%) 25(24.3%) 42.79(17.57,10.17) 20.35 (5.13, 80.58)+
No 7(6.8%) 78(75.7%) 1 1
Occupational status Employed 14(13.6%) 40(38.8%) 1 1
Unemployed 89(86.4%) 63(61.2%) 4.04(2.03,8.04) 0.47(0.12,1.92)
Income ≤25$ 42(40.8%) 69(67.0%) 0.42(0.18,0.99) 1.2(0.28,5.22)
25-50$ 28(27.2%) 14(13.6%) 1.38(0.51,3.74) 0.56(0.09,3.36)
50-100$ 17(16.5%) 9(8.7%) 1.30(0.43,3.96) 1.37(0.20,9.19)
≥100$ 16(15.5%) 11(10.7%) 1 1
Resided in Addis Ababa Yes 80(77.7%) 61(59.2%) 1 1
No 23(22.3%) 42(40.8%) 2.39(1.30,4.40) 2.04(0.65,6.38)
HIV infected Yes 19(18.4%) 48(46.6%) 0.26 (0.13, 0.48) 0.65 (0.01, 0.28)+
No 84(81.6%) 55(53.4%) 1 1
Episodes of TB One 34(33.0%) 90(87.4%) 1 1
More than1 9(67.0%) 13(12.6%) 14.06(6.89,28.63) 15.67 (4.18, 58.71)+ 15.67 (4.18, 58.71)+
Biological TB site Pulmonary 92(93.9%) 21(80.8%) 3.651(1.017,13.10) 6.83 (1.16, 40.17)+
Extra pulmonary 6(6.1%) 5(19.2%) 1 1
Category of treatment Category I 48(46.6%) 96(94.1%) 1 1
Category II 39(37.9%) 2(2.0%) 39.0(9.03,168.37) 16.1 (2.40, 108.56)+
Category III 5(4.9%) 3(2.9%) 3.3 (0.76,14.54) 2.4 (0.29,21.38)
Category IV 11(10.7%) 1(1.0%) 22.0 (2.76,17.4) 7.7 (0.55,109.3)
Ever interrupted anti-TB drug Yes 24(23.3) 10(9.7%) 2.8 (1.27,6.26) 0.2 (0.058,1.11)
No 79(76.7%) 93(90.3%) 1 1
+

Indicates variable that showed significant association at p<0.05